xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.23262, Wiley Online Library on [02/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

436

KUANetal.

Res .

2015;25(6):503-509.

https://doi.org/10.1097/CMR.

1572. Amit M, Tam S, Abdelmeguid AS, et al. Role of adjuvant treatment in sinonasal mucosal melanoma. J Neurol Surg B Skull Base . 2017;78(6):512-518. https://doi.org/10.1055/s-0037 1604350 1573. Grant-Freemantle MC, Lane O’Neill B, Clover AJP. The effec tiveness of radiotherapy in the treatment of head and neck mucosal melanoma: systematic review and meta-analysis. Head Neck . 2021;43(1):323-333. https://doi.org/10.1002/hed. 26470 1574. Konuthula N, Parasher A, Del Signore A, Iloreta AM, Khan M. Role of adjuvant radiation in treatment of sinonasal mucosal melanoma. Otolaryngol Head Neck Surg . 2016;155(Suppl. 1):P80. https://doi.org/10.1177/0194599816655336d 1575. Arturo J, Caudell J, Frakes J, McMullen CP. Elective neck management in head and neck mucosal melanoma. Otolaryn gol Head Neck Surg . 2019;161(2, Suppl.):P240. https://doi.org/ 10.1177/0194599819858142 1576. Manton T, Tillman B, McHugh J, Bellile E, McLean S, McKean E. Sinonasal melanoma: a single institutional analysis and future directions. J Neurol Surg B Skull Base . 2019;80(5):484 492. https://doi.org/10.1055/s-0038-1676355 1577. Lee SP, Shimizu KT, Tran LM, Juillard G, Calcaterra TC. Mucosal melanoma of the head and neck: the impact of local control on survival. Laryngoscope . 1994;104(2):121-126. https:// doi.org/10.1288/00005537-199402000-00001 1578. Samstein R, Barker CA, Carvajal RD, et al. Localized sinonasal mucosal melanoma: outcomes and associations with stage, radiation therapy, and positron emission tomog raphy response. Int J Radiat Oncol Biol Phys . 2016;94(4):949. 1579. Samstein RM, Carvajal RD, Postow MA, et al. Localized sinonasal mucosal melanoma: outcomes and associations with stage, radiotherapy, and positron emission tomography response. HeadNeck . 2016;38(9):1310-1317. https://doi.org/10. 1002/hed.24435 1580. Zenda S, Akimoto T, Mizumoto M, et al. Multicenter phase 2 study of proton beam therapy as a nonsurgical approach for mucosal melanoma of the nasal cavity or paranasal sinuses. Int J Radiat Oncol Biol Phys . 2015;93(3):S212. 1581. Zenda S, Kawashima M, Nishio T, et al. Proton beam ther apy as a nonsurgical approach to mucosal melanoma of the head and neck: a pilot study. Int J Radiat Oncol Biol Phys . 2011;81(1):135-139. https://doi.org/10.1016/j.ijrobp.2010.04.071 1582. Umeda Y, Yoshikawa S, Kiniwa Y, et al. Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA 4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: a retrospective, multicenter study. Eur J Cancer . 2021;157:361-372. https://doi.org/10.1016/ j.ejca.2021.08.034 1583. Dréno M, Georges M, Espitalier F, et al. Sinonasal mucosal melanoma: a 44-case study and literature analysis. Eur Ann Otorhinolaryngol Head Neck Dis . 2017;134(4):237-242. https:// doi.org/10.1016/j.anorl.2017.02.003 1584. Liu HQ, Zou BQ, Wang SY. Expression and prognostic val ues of PD-1, PD-L1 and IDO-1 in sinonasal malignant mucosal melanoma. Zhonghua Bing Li Xue Za Zhi . 2017;46(11):782-788. https://doi.org/10.3760/cma.j.issn.0529-5807.2017.11.009 1585. Thierauf J, Veit JA, Affolter A, et al. Identification and clinical relevance of PD-L1 expression in primary mucosal malignant melanoma of the head and neck. Melanoma

0000000000000197 1586. Zenda S, Akimoto T, Mizumoto M, et al. Phase II study of proton beam therapy as a nonsurgical approach for mucosal melanoma of the nasal cavity or para-nasal sinuses. Radiother Oncol . 2016;118(2):267-271. https://doi.org/10.1016/j. radonc.2015.10.025 1587. Siak PY, Khoo AS, Leong CO, Hoh BP, Cheah SC. Current status and future perspectives about molecular biomarkers of nasopharyngeal carcinoma. Cancers . 2021;13(14):3490. https:// doi.org/10.3390/cancers13143490 1588. Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev . 2006;15(10):1765-1777. https://doi.org/10.1158/1055-9965. EPI-06-0353 1589. Petersson F. Nasopharyngeal carcinoma: a review. Semin Diagn Pathol . 2015;32(1):54-73. https://doi.org/10.1053/j. semdp.2015.02.021 1590. Wong KCW, Hui EP, Lo KW, et al. Nasopharyngeal carcinoma: an evolving paradigm. Nat Rev Clin Oncol . 2021;18(11):679-695. https://doi.org/10.1038/s41571-021-00524 x 1591. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol . 2002;12(6):431-441. https://doi.org/10.1016/ s1044579x0200086x 1592. Punwaney R, Brandwein MS, Zhang DY, et al. Human papillomavirus may be common within nasopharyngeal carcinoma of Caucasian Americans: investigation of Epstein Barr virus and human papillomavirus in eastern and western nasopharyngeal carcinoma using ligation-dependent polymerase chain reaction. Head Neck . 1999;21(1):21-29. https://doi.org/10.1002/(sici)1097-0347(199901)21:1 ⟨ 21::aid hed3 ⟩ 3.0.co;2-z 1593. Pan XX, Liu YJ, Yang W, Chen YF, Tang WB, Li CR. Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients. Laryn goscope . 2020;130(3):E83-E88. https://doi.org/10.1002/ lary.28099 1594. Wu SG, Lian CL, Wang J, et al. The effect of histological sub types on survival outcome in nasopharyngeal carcinoma after extensive follow up. Ann Transl Med . 2019;7(23):768. https:// doi.org/10.21037/atm.2019.11.75 1595. Guo R, Wu H, Wang J, et al. Lymph node status and outcomes for nasopharyngeal carcinoma according to his tological subtypes: a SEER population-based retrospective analysis. Adv Ther . 2019;36(11):3123-3133. https://doi.org/10. 1007/s12325-019-01100-7 1596. Argirion I, Zarins KR, Suwanrungruang K, et al. Subtype specific nasopharyngeal carcinoma incidence and survival trends: differences between endemic and non-endemic popu lations. Asian Pac J Cancer Prev . 2020;21(11):3291-3299. https:// doi.org/10.31557/apjcp.2020.21.11.3291 1597. Colaco RJ, Betts G, Donne A, et al. Nasopharyngeal carci noma: a retrospective review of demographics, treatment and patient outcome in a single centre. ClinOncol . 2013;25(3):171 177. https://doi.org/10.1016/j.clon.2012.10.006 1598. Vazquez A, Khan MN, Govindaraj S, Baredes S, Eloy JA. Nasopharyngeal squamous cell carcinoma: a comparative analysis of keratinizing and nonkeratinizing subtypes. Int